title: Optimizing dual antiplatelet therapy duration after myocardial infarction: evidence-based, precision, or personalized medicine?
authors.forename: Fernando
authors.initials: F
authors.lastname: Alfonso
authors.forename: Luis Jesús
authors.initials: LJ
authors.lastname: Jiménez-Borreguero
mesh_terms: D001241:Aspirin; D004359:Drug Therapy, Combination; D006801:Humans; D009203:Myocardial Infarction; D010975:Platelet Aggregation Inhibitors; D057285:Precision Medicine; D013988:Ticlopidine
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin